- Home
- CCEL vs OSTX Comparison
CCEL vs OSTX Comparison
Compare CCEL & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- OSTX
- Stock Information
- Founded
- CCEL 1989
- OSTX 2018
- Country
- CCEL United States
- OSTX United States
- Employees
- CCEL N/A
- OSTX N/A
- Industry
- CCEL Managed Health Care
- OSTX
- Sector
- CCEL Health Care
- OSTX
- Exchange
- CCEL Nasdaq
- OSTX NYSE
- Market Cap
- CCEL 39.9M
- OSTX 43.0M
- IPO Year
- CCEL 1997
- OSTX 2024
- Fundamental
- Price
- CCEL $5.13
- OSTX $1.81
- Analyst Decision
- CCEL Strong Buy
- OSTX Strong Buy
- Analyst Count
- CCEL 1
- OSTX 3
- Target Price
- CCEL $8.50
- OSTX $18.00
- AVG Volume (30 Days)
- CCEL 8.3K
- OSTX 301.8K
- Earning Date
- CCEL 07-14-2025
- OSTX 08-14-2025
- Dividend Yield
- CCEL 7.97%
- OSTX N/A
- EPS Growth
- CCEL N/A
- OSTX N/A
- EPS
- CCEL 0.01
- OSTX N/A
- Revenue
- CCEL $32,102,750.00
- OSTX N/A
- Revenue This Year
- CCEL $2.49
- OSTX N/A
- Revenue Next Year
- CCEL $0.95
- OSTX N/A
- P/E Ratio
- CCEL $555.99
- OSTX N/A
- Revenue Growth
- CCEL 2.33
- OSTX N/A
- 52 Week Low
- CCEL $4.75
- OSTX $1.12
- 52 Week High
- CCEL $9.43
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- CCEL 50.16
- OSTX N/A
- Support Level
- CCEL $5.00
- OSTX N/A
- Resistance Level
- CCEL $5.31
- OSTX N/A
- Average True Range (ATR)
- CCEL 0.22
- OSTX 0.00
- MACD
- CCEL 0.02
- OSTX 0.00
- Stochastic Oscillator
- CCEL 43.09
- OSTX 0.00
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.